A Medicines Safety Update from the TGA has reminded health professionals to be cautious with parenteral administration of hyoscine butylbromide (Buscopan) via intramuscular or slow intravenous injection. The Product Information for hyoscine butylbromide is being updated to include a stronger warning about its use in patients with cardiac conditions. The updated PI will advise that ...
Cardiac risk with antispasmodic medications
14 Sep 2017